Searched for
MANKIND PHARMA LISTING NEWS
Nifty eyes 25,000 as July rally builds; banking, realty and auto lead the charge: Rohit SrivastavaMarket strategist Rohit Srivastava anticipates a strong summer for Indian equities, with the Nifty poised for gains. He highlights banking,...- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- TNEA Counselling Rank List 2026 released at tneaonline.org; how to check ranks, counselling details and moreTNEA 2026 Rank list released: Tamil Nadu's engineering admissions for 2026 have seen a highly competitive year, with 53 students scoring a ...
- Advit Jewels shares list at 37% premium over IPO price on NSE, BSEAdvit Jewels shares made a blockbuster stock market debut on Wednesday, listing at up to a 36% premium over the IPO price after the issue w...
- Who is Guo Wengui? 10 things to know about the exiled Chinese billionaire sentenced to 30 years in US prisonGuo Wengui, the Self-exiled Chinese businessman, has been sentenced to 30 years in prison for orchestrating a massive fraud scheme. Prosecu...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- Anubhav Plast shares list flat at IPO price of Rs 80 on BSE SME platformAnubhav Plast shares debuted at their IPO price of Rs 80 on the BSE SME platform, mirroring grey market expectations. The company's Rs 80 c...
- Turtlemint Fintech shares list at 11% discount to IPO price on NSE, BSETurtlemint Fintech Solutions experienced a subdued market debut, with shares listing at a discount to their IPO price on both NSE and BSE. ...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- OpenAI weighs IPO in 2027 after expected Anthropic public debutAI giant OpenAI is reportedly eyeing a 2027 initial public offering, potentially after rival Anthropic. Both companies have confidentially ...
- Drone startup Elroy Air to list on Nasdaq via $1 billion SPAC dealCargo drone startup Elroy Air is set to go public in the US through a $1 billion merger with blank-check firm Columbus Circle Capital Corp ...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
Load More
